TY - JOUR T1 - Social-economic drivers overwhelm climate in underlying the COVID-19 early growth rate JF - medRxiv DO - 10.1101/2021.09.10.21263383 SP - 2021.09.10.21263383 AU - Zhenghua Liu Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/09/15/2021.09.10.21263383.abstract N2 - Identifying the drivers underlying the spatial occurrence and spreading rate of COVID-19 can provide valuable information for their preventions and controls. Here, we examine how socio-economic and climate drivers affect the early growth rates of COVID-19 in China and the other countries, the former of which have consistently stricter quarantine during early epidemic and thus are used to enquire the influences of human interventions on trainsimissions. We find that the early growth rates of COVID-19 are higher in China than the other countries, which is consistent with previous reports. The global spread is mainly driven by the socio-economic factors such as GDP per capita, human movement and population density rather than climate. Among socio-economic factors, GDP per capita is most important showing negative relationships in China, while positive in the other countries. However, the predicability of early growth rates by socio-economic and climate variables is at least 1.6 times higher in China’s provinces than the other countries, which is further supported by metapopulation network model. These findings collectively indicate that the stochasticity of transimission processes decrease upon strict quarantine measures such as travel restrictions.Key findingsGDP per capita is most important in driving the spread of COVID-19, which shows negative relationships within China, while positive in the other countries.Socio-economic and climate factors are key in driving the early growth rate of COVID-19, while the former is more important.Socio-economic and climate features explain more variations of early growth rates in China due to the decreased stochasticity of transimission processes upon strict quarantine measures.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNAAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and R codes are available on https://github.com/zhenghualiu/COVID-19/tree/master/Rcodes. https://github.com/zhenghualiu/COVID-19 ER -